Xylem Inc.
For the period ended Sep 30, 2025. Filed Oct 28, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 28, 2025
XYL$97.83-2.2%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements:
PART I
ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
(in millions, except per share data)
| Three Months | Nine Months | |||
|---|---|---|---|---|
| For the periods ended September 30, | 2025 | 2024 | 2025 | 2024 |
| Revenue from products | $1,867 | $1,744 | $5,487 | $5,236 |
| Revenue from services | 401 | 360 | 1,151 | 1,070 |
| Revenue | 2,268 | 2,104 | 6,638 | 6,306 |
| Cost of revenue from products | 1,109 | 1,047 | 3,279 | 3,147 |
| Cost of revenue from services | 276 | 273 | 816 | 804 |
| Cost of revenue | 1,385 | 1,320 | 4,095 | 3,951 |
| Gross profit | 883 | 784 | 2,543 | 2,355 |
| Selling, general and administrative expenses | 474 | 445 | 1,437 | 1,404 |
| Research and development expenses | 52 | 55 | 166 | 172 |
| Restructuring and asset impairment charges | 23 | 4 | 70 | 37 |
| Operating income | 334 | 280 | 870 | 742 |
| Interest expense | (6) | (10) | (23) | (35) |
| Other non-operating income, net | 6 | 1 | 13 | 11 |
| Loss on sale of businesses | (37) | (2) | (47) | (6) |
| Income before taxes | 297 | 269 | 813 | 712 |
| Income tax expense | (71) | (52) | (196) | (148) |
| Net income | $226 | $217 | $617 | $564 |
| Net loss attributable to non-controlling interests | 1 | — | 5 | — |
| Net income attributable to Xylem | $227 | $217 | $622 | $564 |
| Earnings per share: | ||||
| Basic | $0.93 | $0.89 | $2.56 | $2.33 |
| Diluted | $0.93 | $0.89 | $2.55 | $2.32 |
| Weighted average number of shares: | ||||
| Basic | 243.5 | 242.9 | 243.3 | 242.5 |
| Diluted | 244.1 | 243.8 | 243.9 | 243.4 |
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(in millions)
| Three Months | Nine Months | |||
|---|---|---|---|---|
| For the periods ended September 30, | 2025 | 2024 | 2025 | 2024 |
| Net income | $226 | $217 | $617 | $564 |
| Other comprehensive (loss) income, before tax: | ||||
| Foreign currency translation adjustment | (6) | 97 | 87 | 38 |
| Amount of currency translation adjustment relating to divestiture of foreign subsidiaries reclassified into net income | — | — | 8 | — |
| Net change in derivative hedge agreements: | ||||
| Unrealized gain | 1 | 3 | 31 | — |
| Amount of (gain) loss reclassified into net income | (5) | 2 | (2) | 2 |
| Net change in post-retirement benefit plans: | ||||
| Amortization of prior service credit | — | — | — | (1) |
| Amortization of net actuarial loss into net income | — | — | 1 | 1 |
| Foreign currency translation adjustment | 1 | (2) | (2) | — |
| Other comprehensive (loss) income, before tax | (9) | 100 | 123 | 40 |
| Income tax expense (benefit) related to items of other comprehensive (loss) income | 2 | (13) | (79) | 3 |
| Other comprehensive (loss) income, net of tax | (11) | 113 | 202 | 37 |
| Comprehensive income | $215 | $330 | $819 | $601 |
| Comprehensive loss attributable to non-controlling interest | 1 | — | 5 | — |
| Comprehensive income attributable to Xylem | $216 | $330 | $824 | $601 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.